The Withings Body Scan 2 was officially launched today after receiving regulatory approvals. It is an ultra-premium scale priced at $600, aimed at consumers looking for advanced health monitoring at home.
The Body Scan 2 boasts an upgrade in its scanning capabilities, now analyzing 60 biomarkers. This signifies a substantial enhancement from the original model, which provided 40. Key features include Impedance Cardiography (ICG) for heart monitoring and Bioimpedance Spectroscopy (BIS) for assessing body water levels.
Withings claims that the Body Scan 2 provides data comparable to clinical-grade DEXA scans, which are typically used for body composition analysis. This positions the scale as a cost-effective solution in the health-monitoring segment.
Purchasing the Body Scan 2 includes a complimentary one-month trial of Withings+, the company's premium health-monitoring service. This trial allows users to access additional features and analyses post-purchase.
✨ This summary was generated by AI from the outlets' reporting listed below. It is not independently verified and may contain errors — check the original sources. How BrevFeed works →
One email each morning: the day's tech stories, clustered across outlets and summarized. No account needed.
One email a day. Unsubscribe in one click, any time.
Spend a few minutes, get the whole day. Every topic's top stories in one hands-free rundown — listen, watch, or read the transcript.
▶ Play today's briefNew every morning, and the back catalogue is archived by date.
Withings has launched the Body Scan 2, an ultra-premium scale now available for $600 in the US. It offers enhanced health monitoring with 60 biomarkers compared to 40 in the previous model, including features like Impedance Cardiography and Bioimpedance Spectroscopy.